Staff NewsSep 25, 2026
Enveda raises $311 million for natural-product drug pipeline
The Series E will fund later-stage work for three clinical medicines and more trials in inflammatory and metabolic conditions.
By Nifal Adam, Go Big News Staff

Software covered and reviewed by AI.
Match products by what your business actually needs.
Launches, funding rounds, and startup company news.
The Series E will fund later-stage work for three clinical medicines and more trials in inflammatory and metabolic conditions.
By Nifal Adam, Go Big News Staff


YC-backed Oasive has launched a fixed-income research platform for investors comparing bonds and testing risk before trades.

Micky said bezalel.sh now has monthly recurring revenue after landing its first customer. The announcement did not disclose the customer, pricing or revenue amount.

The clinical AI company combined a US$100M Series C with a US$240M General Catalyst growth investment. The Series C values Heidi at US$900 million post-money.













































